Thyrocare Technologies advances on launching ‘FocusTB’

01 Jan 2018 Evaluate

Thyrocare Technologies is currently trading at Rs. 701.20, up by 11.40 points or 1.65% from its previous closing of Rs. 689.80 on the BSE.

The scrip opened at Rs. 694.50 and has touched a high and low of Rs. 701.25 and Rs. 694.50 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 779.90 on 06-Apr-2017 and a 52 week low of Rs. 611.10 on 05-Dec-2017.

Last one week high and low of the scrip stood at Rs. 704.30 and Rs. 685.00 respectively. The current market cap of the company is Rs. 3,767.00 crore.

The promoters holding in the company stood at 63.96%, while Institutions and Non-Institutions held 25.74% and 10.29% respectively.

Thyrocare Technologies has launched ‘FocusTB’, its affordable brand focusing on TB diagnostics. FocusTB services are available throughout India through Thyrocare’s Pan Asian network with more than 30,000 sample collection points.

Thyrocare Technologies is India’s first fully automated diagnostics services provider with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.


Thyrocare Tech. Share Price

410.70 -17.40 (-4.06%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×